The history and DNA of our company
Acar'Up Consumer Health is a Belgian healthcare company headquartered in the capital city of Brussels. We own exclusive worldwide rights ExAller anti-dust mite product, which is developed and produced in Belgium.
Our roots in high-quality scientific research
Researchers at the ULB and UCL universities in Brussels have studied the biology and behaviour of dust mites for many years, leading to the development of an innovative plant-based product in 2014 that attracts dust mites by mimicking their own communication pheromones.
Clinical research has demonstrated the effectiveness of this product at attracting dust mites, as well as significant symptom reductions in allergic children. Acar’Up Consumer health was formed as a collaborative spin-off of these universities and began scaling up production and marketing activities.
Rapid success and expansion
The anti-dust mite product was launched in Belgium in 2014 as Acar’Up, rapidly becoming the first-line therapy prescribed by allergists and doctors. Sales have increased year on year.
In 2017, the board of directors decided to introduce the product in several countries around the world. Acar’Up Consumer Health joined forces with several venture capital funds, underwent a capital increase operation and hired a CEO with decades of experience in international marketing of consumer health products.
Acar’Up Consumer Health has the vision to become the global leader in prevention and treatment of allergic symptoms caused by dust mites.
Our board of Directors
Chairwoman
INNOVATION FUND REPRESENTED BY
EDITH COUNE
The Innovation Fund was created in February 2015. The fund invests in innovative start-ups and companies active in the fields of chemicals and life sciences. With the Innovation Circle and Fund, essenscia and François Cornelis have created a one-stop shop for creative and innovative companies in the Belgian chemicals sector.
Edith Coune has more than 20 years of experience in the chemical industry. Among others, she has held the position of communication manager at BASF. Edith has been the general secretary of the Innovation Circle and the Innovation Fund since their creation.
CHIEF EXECUTIVE OFFICER (CEO)
JONATHAN FELDBRUGGE
Jonathan Feldbrugge has over 12 years of international experience in the healthcare industry. In 2011, he became head of a Belgian company focussing on self-care. In 2013, he founded a subsidiary in Luxembourg, then continued his entrpreneurial journey in Switzerland in 2017.
He joined Acar'Up Consumer Health in 2020 and took the position of CEO in 2022. He expanded the ExAller© brand in multiple countries and in now leading the company successfully.
THEODORUS III S.A. REPRESENTED BY
ADRIEN VAN DER BORGHT
Theodorus is the spin-off investment fund of the Université Libre de Bruxelles (ULB). Its primary mission is to finance companies created based on innovative technologies developed within or in collaboration with the university.
Adrien joined Thedorus Investment Funds in 2018. Previously, he worked as a consultant with the Boston Consulting Group, where he primarily served the medical and industrial sectors in a wide range of areas. He holds a master's degree from the Solvay Business School.
INVENTURES S.A. REPRESENTED BY
BRUNO DE RADZITZKY
Inventures is a European venture capital fund that builds a better world by investing in fast-growing companies and sustainable businesses led by ambitious and visionary founders.
Bruno de Radzitzky has almost 25 years of experience in M&A transactions. He started his career as a lawyer and member of the Brussels Bar. He then joined Etex (a Belgian group active in building materials around the world) as a corporate lawyer, later becoming senior legal counsel. He joined Inventures on 1 January 2017 as head of asset management.